Tenomix Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
22
Tenomix General Information
Description
Developer of a cancer screening device designed to improve the staging process of colorectal cancers. The company's device guides pathology staff in efficient and reliable lymph node collection in surgically removed colon cancer tissues for accurate identification of cancer spread, enabling clients to optimize cancer care and reduce healthcare costs.
Contact Information
Website
www.tenomix.comCorporate Office
- 6th floor, Robarts Research Building, Western University
- 100 Perth Drive
- London, Ontario N6A 5K8
- Canada
Corporate Office
- 6th floor, Robarts Research Building, Western University
- 100 Perth Drive
- London, Ontario N6A 5K8
- Canada
Tenomix Timeline
Tenomix Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 23. Accelerator/Incubator | 17-Oct-2025 | Completed | Generating Revenue | |||
| 22. Accelerator/Incubator | 05-Aug-2025 | Completed | Generating Revenue | |||
| 21. Accelerator/Incubator | 08-Jan-2025 | Completed | Generating Revenue | |||
| 20. Accelerator/Incubator | 15-Mar-2024 | Completed | Generating Revenue | |||
| 19. Accelerator/Incubator | 12-Mar-2024 | Completed | Generating Revenue | |||
| 18. Early Stage VC | 08-Mar-2024 | Completed | Generating Revenue | |||
| 17. Accelerator/Incubator | 01-Jan-2024 | Completed | Startup | |||
| 16. Accelerator/Incubator | 01-Jan-2024 | Completed | Startup | |||
| 15. Accelerator/Incubator | $5K | $140K | Completed | Startup | ||
| 14. Accelerator/Incubator | 01-Jan-2023 | $50K | $135K | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Tenomix Patents
Tenomix Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026220278-A1 | Systems and method for tissue excision | Pending | 14-Apr-2025 |
Tenomix Signals
Tenomix Investors (22)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Endless Frontier Labs | Accelerator/Incubator | Minority | ||
| Vector Institute | Corporation | |||
| MassRobotics | Accelerator/Incubator | |||
| BioNext (Canada) | Accelerator/Incubator | |||
| Ontario Bioscience Innovation Organization | Not-For-Profit Venture Capital | Minority |
Tenomix FAQs
-
When was Tenomix founded?
Tenomix was founded in 2021.
-
Where is Tenomix headquartered?
Tenomix is headquartered in London, Canada.
-
What is the size of Tenomix?
Tenomix has 9 total employees.
-
What industry is Tenomix in?
Tenomix’s primary industry is Diagnostic Equipment.
-
Is Tenomix a private or public company?
Tenomix is a Private company.
-
What is Tenomix’s current revenue?
The current revenue for Tenomix is .
-
How much funding has Tenomix raised over time?
Tenomix has raised $2.09M.
-
Who are Tenomix’s investors?
Endless Frontier Labs, Vector Institute, MassRobotics, BioNext (Canada), and Ontario Bioscience Innovation Organization are 5 of 22 investors who have invested in Tenomix.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process